Drug Discovery World

APRIL 24, 2024

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has supported the use of artificial intelligence (AI) to deliver benefit for patients, life science companies and society, in response to the EU Artificial Intelligence (AI) Act.

Pharma R&D 130

Pharma R&D Government Regulations Drug Development 130

BenchSci

MARCH 6, 2024

While we have made tremendous progress in drug discovery over the last couple of decades, the process of discovering new drugs is time-consuming, intricate, and costly. Today, the pharmaceutical (pharma) industry is in the midst of a transformative era driven by the advent of Generative AI (GenAI).

Pharma R&D 52

Pharma R&D Clinical Trials Pharmaceuticals Trials 52

Drug Discovery World

AUGUST 7, 2024

Ashu Singhal and Sajith Wickramasekara , co-founders of Benchling, explore how AI’s true promise for the pharmaceutical industry can only be realised if the entire pharmaceutical R&D lifecycle is supported. Drug discovery has quickly become a trendy place to apply AI.

Pharma R&D 173

Pharma R&D Clinical Trials Pharma Companies Trials 173

The Pharma Data

JANUARY 10, 2021

.–( BUSINESS WIRE )– Boehringer Ingelheim announced today a collaborative agreement with Google Quantum AI (Google), focusing on researching and implementing cutting-edge use cases for quantum computing in pharmaceutical research and development (R&D), specifically including molecular dynamics simulations.

Pharma R&D 40

Pharma R&D Pharmaceuticals Pharmaceutical Companies Disease 40